Betadine against SARS-CoV-2

Effectiveness of BETADINE Antiseptic Products against SARS-CoV-2. Mundipharma had announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE antiseptic products against the novel coronavirus (SARS-CoV-2) that causes COVID-19 disease. Testing has demonstrated BETADINE’s strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The products subjected to testing were: BETADINE antiseptic products, namely Solution (10% PVP-I), Skin Cleanser (7.5% PVP-I), Gargle and Mouthwash (1.0% PVP-I) and Throat Spray (0.45% PVP-I). These results confirm the view that BETADINE antiseptic products, used appropriately and in conjunction with other preventative treatment options including PPE, can play a role in limiting the spread of infections, including COVID-19. It also provides the medical community as well as consumers with a science-based assurance that they are using a product that is a proven defense against COVID-19. Previously, BETADINE antiseptic products containing povidone iodine (PVP-I) have been proven effective in vitro against a wide range of viruses, including coronaviruses that have caused major outbreaks such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The BETADINE antiseptic range contains Povidone-iodine (PVP-I), which is highly effective against a wide range of microorganisms, including bacteria, viruses and fungi and is typically used in hospitals.

12 Likes

LikeAnswersShare

A new update for all of us . May be it will help -surgeons , Gynaecologists and orthopedic surgeons as they are using betadine scrub - prior to all surgeries

Valuable opinion
0

As per icmr add in list if advantage

Nice information

Thank you doctor
0

Very well illustrated

Thank you doctor
0

Intresting update

Informative

Cases that would interest you